Search research articles
Contact Us
Filters
Showing results (21-30 of 68) with videos related to
Page
of 7
Sort By:
Drugs & Aging
|
May 25, 2017
Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life
Giulia Grande, Lucas Morin, Davide Liborio Vetrano, et al.
Expert Opinion on Drug Safety
|
December 13, 2018
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Jonas W Wastesson, Lucas Morin, Edwin C K Tan, et al.
European Journal of Clinical Pharmacology
|
June 24, 2018
Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus
Lucas Morin, Marie-Laure Laroche, Davide L Vetrano, et al.
Palliative Medicine
|
June 8, 2019
How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study
Lucas Morin, Jonas W Wastesson, Marie-Laure Laroche, et al.
BMJ Open
|
November 10, 2021
Effectiveness of interventions to address the negative health outcomes of informal caregiving to older adults: protocol for an umbrella review
Amaia Calderón-Larrañaga, Mariam Kirvalidze, Lena Dahlberg, et al.
Acta Dermato-Venereologica
|
November 29, 2021
Increase in American Joint Committee on Cancer Stage at Diagnosis for Patients with Skin Cancers after the COVID-19 Lockdown
Charlée Nardin, Lise Senot, Paul Pernot, et al.
Clinical Epidemiology
|
March 22, 2018
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Lucas Morin, Kristina Johnell, Marie-Laure Laroche, et al.
Cancer
|
March 26, 2019
Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
Lucas Morin, Adam Todd, Stephen Barclay, et al.
Journal of the American Medical Directors Association
|
April 23, 2017
Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia
Lucas Morin, Davide L Vetrano, Giulia Grande, et al.
Nature Communications
|
August 2, 2024
PatCID: an open-access dataset of chemical structures in patent documents
Lucas Morin, Valéry Weber, Gerhard Ingmar Meijer, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 68) with videos related to
Sort By:
Page
of 7
Drugs & Aging
|
May 25, 2017
Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life
Giulia Grande, Lucas Morin, Davide Liborio Vetrano, et al.
Expert Opinion on Drug Safety
|
December 13, 2018
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Jonas W Wastesson, Lucas Morin, Edwin C K Tan, et al.
European Journal of Clinical Pharmacology
|
June 24, 2018
Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus
Lucas Morin, Marie-Laure Laroche, Davide L Vetrano, et al.
Palliative Medicine
|
June 8, 2019
How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study
Lucas Morin, Jonas W Wastesson, Marie-Laure Laroche, et al.
BMJ Open
|
November 10, 2021
Effectiveness of interventions to address the negative health outcomes of informal caregiving to older adults: protocol for an umbrella review
Amaia Calderón-Larrañaga, Mariam Kirvalidze, Lena Dahlberg, et al.
Acta Dermato-Venereologica
|
November 29, 2021
Increase in American Joint Committee on Cancer Stage at Diagnosis for Patients with Skin Cancers after the COVID-19 Lockdown
Charlée Nardin, Lise Senot, Paul Pernot, et al.
Clinical Epidemiology
|
March 22, 2018
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Lucas Morin, Kristina Johnell, Marie-Laure Laroche, et al.
Cancer
|
March 26, 2019
Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
Lucas Morin, Adam Todd, Stephen Barclay, et al.
Journal of the American Medical Directors Association
|
April 23, 2017
Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia
Lucas Morin, Davide L Vetrano, Giulia Grande, et al.
Nature Communications
|
August 2, 2024
PatCID: an open-access dataset of chemical structures in patent documents
Lucas Morin, Valéry Weber, Gerhard Ingmar Meijer, et al.
Page
of 7